BLOG

contagion

Heat Biologics gp96 Vaccine Effort Aims for T Cell Immunity

Heat Biologics CEO Jeff Wolf talks with Contagion about the firm’s effort to develop a vaccine for the coronavirus focused on combining antibody and T cell immunity using the GP-96 protein.